Ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID). It works by blocking your body's production of certain natural substances that cause inflammation.

Beroe LiVE.Ai™

AI-powered self-service platform for all your sourcing decision needs across 1,200+ categories like Ibuprofen.

Market Data, Sourcing & Supplier Intelligence, and Price & Cost Benchmarking.

Schedule a Demo

Ibuprofen Market Monitoring Dashboard

Understand the correlation between costs, margins, and prices impacting your category on a real time basis on Beroe LiVE.Ai™

Schedule a Demo

Ibuprofen Industry Benchmarks

Savings Achieved

(in %)

The average annual savings achieved in Ibuprofen category is 20.10%

Payment Terms

(in days)

The industry average payment terms in Ibuprofen category for the current quarter is 54.3 days

Compare your category performance against peers and industry benchmarks across 20+ parameters on Beroe LiVE.Ai™

Category Strategy and Flexibility

Engagement Model

Supply Assurance

Sourcing Process

Supplier Type

Pricing Model

Contract Length


Lead Time

Supplier Diversity

Targeted Savings

Risk Mitigation

Financial Risk



Geopolitical Risk

Cost Optimization

Price per Unit Competitiveness

Specification Leanness

Minimum Order Quality

Payment Terms

Inventory Control

Schedule a Demo
Meet Abi

The World’s first Digital Market Analyst

    Meet Abi

    The World’s first Digital Market Analyst

    Abi, the AI-powered digital assistant brings together data, insights, and intelligence for faster answers to sourcing questions

    Abi is now supercharged with GPT4 AI engine. Enjoy the ease of ChatGPT, now on Abi

    Ibuprofen Market Intelligence

    global market outlook

      • The global market value is around $630 million in 2022, and the market is expected to grow at a CAGR of ~5% till 2025
      • The major market for Ibuprofen is North America, India, Europe and China. China has accounted for nearly 48 percent of the global production of Ibuprofen. India shares 30.7 percent in the global production. Exports have increased drastically to cater to the global demand
      • The current global Ibuprofen market size is estimated to be ~45,000MT and would grow at ~2 percent, in line with estimated growth in Ibuprofen Finished Dosage
      • Raw materials account for 60-65 percent of the total cost of production. IBB is the major raw material for manufacturing Ibuprofen and accounts for around 25 percent of the raw material cost, with sodium dichromate accounting for 17 percent of cos
      • IOL, Solara, Shandong Xinhua, BASF, Granules Biocause, and SI Group are the Top-6 Ibuprofen suppliers in the world, with an estimated 80–85 percent market share

    Ibuprofen market frequently asked questions

    The total Ibuprofen market size is estimated to be about 43,000 MT as of 2017 and growing at a CAGR of 2 percent

    Shasun is the market leader with about 16 percent market share. Considering the utilization rates, the SI group and IOLCP are the lowest among the top players. BASF and IOLCP are the only two players expanding capacity for Ibuprofen. The capacity expansion for Ibuprofen at BASF's Texas, US and Ludwigshafen, Germany sites will be operational by 2021. The IOLCP had expanded its capacity to 7200 in 2017 from 6200 in 2015.

    Due to the increase in prices of the raw materials, Ibuprofen prices have increased by 22 percent. The prices for Isobutyl Benzene, Aluminium Chloride, and Sodium metal also increased by 11 percent, 4 percent and 5 percent respectively. Furthermore, the SI group increased its Ibuprofen price by 40 percent in June 2016. However, this Ibuprofen price trend didn't reflect in the rest of the market.

    Ibuprofen market report transcript

    Global Market Outlook on Ibuprofen

    • The global market value is $630 million in 2022, and it is expected to grow at a steady rate of 5 percent, due to continuous demand for low-cost non-steroidal anti-inflammatory drugs (NSAID) and scale and age of manufacturing facilities

    • The pharmaceutical is the end-use industry for Ibuprofen. The increasing API drug shortages, gathering task force to overcome shortages, emergence of cost-effective drug manufacturers in different countries and supply of API drugs in the developed nations are driving the API growth

    • A considerable crunch in supply and demand of Ibuprofen API ceased production from major Ibuprofen API manufactures, supply chain disruption in China, further led by declining sale in India

    Market Overview: Ibuprofen

    • The Ibuprofen market is expected to grow at a significant market share during the forecast period, owing to the continuous demand for low-cost non-steroidal anti-inflammatory drugs (NSAID) and scale and age of manufacturing facilities.

    • The global market size by revenue of Ibuprofen API is at $660 million in 2022, with a CAGR of 5 percent, and is expected to grow by $750 million by 2025

    • The current global Ibuprofen market size is estimated to be ~45,000MT and would grow at ~2 percent, in line with estimated growth in Ibuprofen Finished Dosage

    • IOL Chemicals and Pharmaceuticals Ltd., the world’s biggest producer of Ibuprofen contributing 22 percent, supplies about a third of the world’s requirement of the drug, with around 10 percent coming from China’s Hubei Biocause Pharmaceutical Co.

    • Solara is now the second-largest Ibuprofen API manufacturer by capacity, with a capacity expansion of 3,600 MT 

    • IOL, Solara, Shandong Xinhua, BASF, Granules Biocause, and SI Group are the Top-6 Ibuprofen suppliers in the world, with an estimated 80–85 percent market share

    Cost Structure for Production of Ibuprofen

    • The raw material cost varies according to the grade of the API & Excipients used and has a major impact on the production cost.

    • The utility cost involves the electricity cost (For Formulation & Conversion) and water cost (For clean-up of the vessels) which has a very low impact on the total cost of production.

    • The labor cost is not so significant, mainly due to the fully automated process for the production process.

    Cost Drivers: Ibuprofen

    • China, being the world’s leading manufacturer of API, resumes its production after the pandemic lockdown, the prices of active pharmaceutical ingredients of the top-selling drugs, including the Ibuprofen, have risen up by 5-15 percent.

    • Ibuprofen prices have started to rise since Q1 2023 significantly worldwide, especially in APAC. Daily COVID-19 instances are increasing in China yet conventional cold medicines like Ibuprofen are low in supply in the US, Canada, some part of EU and even China.

    • As a result, Chinese pharmaceuticals have asked Indian manufacturers to increase the supply of Ibuprofen due to unmanageable demand, this may have led to an increase in the prices of the API and the production costs which further influences the market prices.

    • Owing to the COVID-19 pandemic, the global demand for medicine became higher than usual, which has pushed China to increase the prices of the APIs

    • Increase in the API drug shortages, emergence of cost-effective drug manufacturers in various countries, and supply of API drugs increase the price of the API

    • Also, high open cost and low margin level in Ibuprofen API have resulted in 20–30 percent price spike in final drug formulations and lower sales

    • Moreover, higher volume handling by Contract Manufacturing Organizations compared to pharmaceutical companies and among higher production capabilities and price benefit over pharmaceutical companies are expected to generate considerable revenue pockets

    Why You Should Buy This Report

    • The Ibuprofen market report gives information and an Ibuprofen market analysis about the regional and global Ibuprofen market size,  pharma drug development and manufacturing, ibuprofen market forecast, supply-demand trends, market trends, trade dynamics, import-export, market forecast, etc.
    • The global market outlook section details the overall global market and also studies the global supply market outlook and the global demand market outlook separately. This is a very useful section as the dynamics and the geographies of the main importers and major exporters are different. The market details are also studied regionally. 
    • The other uses and downstream drivers of Ibuprofen such as analgesics, over the counter analgesic, pain reliever, anti-inflammatory, generic variants, Brufen, Rufen, Nurofen, Ibuprofen, Brufen, and other formulations for fever, as a pain reliever tablet, rheumatoid and osteoarthritis are also studied.
    • It gives Porter’s five forces analysis of Asia, Europe, and North America and lists out the major Ibuprofen industry drivers and constraints.
    • The Ibuprofen market report does a cost structure and pricing analysis and gives the Ibuprofen price trend, etc.
    • It gives an overview of the supplier landscape and the SWOT analysis of major players.

    Interesting Reads:

    Discover the world of market intelligence and how it can elevate your business strategies.

    Learn more about how market intelligence can enable informed decision-making, help identify growth opportunities, manage risks, and shape your business's strategic direction.

    Get Ahead with AI-Enabled Market Insights Schedule a Demo Now

    Schedule a Demo Now